Storia in 2 fonti

Another big deal, another sign biotech M&A is back

AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout

Raccontata da

statnews.com

forbes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 mese fa

Another big deal, another sign biotech M&A is back

AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout

originale

forbes.com1 mese fa

AbbVie's Big Immunology Acquisition

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.

Leggi questa versione → originale

Timeline cronologica

lunedì 22 giugno 2026·statnews.com
Pharma goes on a spending spree, snapping up biotechs in a hurry
Pharmaceutical companies are hungry to make deals, and they’re making more than they have in years.
lunedì 22 giugno 2026·statnews.com
Another big deal, another sign biotech M&A is back
AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout

Another big deal, another sign biotech M&A is back

AbbVie's Big Immunology Acquisition

Timeline cronologica

Pharma goes on a spending spree, snapping up biotechs in a hurry

Another big deal, another sign biotech M&A is back

AbbVie's Big Immunology Acquisition

At BIO, a glimpse behind Lilly and Chai’s partnership